New data reveals that retatrutide, a dual-action medication, might represent a major improvement in size reduction . This treatment combines the effects of a GLP-1 analog and a GIP agonist , seemingly https://sociallytraffic.com/story6644745/a-new-breakthrough-for-body-regulation